Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Blood Cancer Journal
|
July 20, 2023
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
Arleigh McCurdy, Hira Mian, Richard LeBlanc, et al.
Blood Cancer Journal
|
August 27, 2023
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
Arleigh McCurdy, Hira Mian, Richard LeBlanc, et al.
Transplantation and Cellular Therapy
|
July 6, 2024
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
Christopher P Venner, Peter Duggan, Kevin Song, et al.
Blood Cancer Journal
|
September 5, 2023
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Julie Côté, Richard LeBlanc, Hira Mian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 28, 2025
Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database
Julia Varghese, Christopher P Venner, Martha Louzada, et al.
Cancer Medicine
|
November 5, 2024
Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study
Mégane Tanguay, Jean Roy, Jiandong Su, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 29, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database
Rayan Kaedbey, Christopher P Venner, Donna Reece, et al.
Cancer
|
October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial
Jolie Ringash, Heather-Jane Au, Lillian L Siu, et al.
Ejhaem
|
July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 1, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
Gary J Schiller, Brea C Lipe, Nizar J Bahlis, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Blood Cancer Journal
|
July 20, 2023
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
Arleigh McCurdy, Hira Mian, Richard LeBlanc, et al.
Blood Cancer Journal
|
August 27, 2023
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
Arleigh McCurdy, Hira Mian, Richard LeBlanc, et al.
Transplantation and Cellular Therapy
|
July 6, 2024
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
Christopher P Venner, Peter Duggan, Kevin Song, et al.
Blood Cancer Journal
|
September 5, 2023
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Julie Côté, Richard LeBlanc, Hira Mian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 28, 2025
Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database
Julia Varghese, Christopher P Venner, Martha Louzada, et al.
Cancer Medicine
|
November 5, 2024
Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study
Mégane Tanguay, Jean Roy, Jiandong Su, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 29, 2025
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database
Rayan Kaedbey, Christopher P Venner, Donna Reece, et al.
Cancer
|
October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial
Jolie Ringash, Heather-Jane Au, Lillian L Siu, et al.
Ejhaem
|
July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 1, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
Gary J Schiller, Brea C Lipe, Nizar J Bahlis, et al.
Page
of 7